|
TTC39B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.61439989049472E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32890000115182E-08 |
| Normal-vs-Stage2 |
4.68839966849544E-10 |
| Normal-vs-Stage3 |
5.99970000014771E-07 |
| Normal-vs-Stage4 |
3.62159968680942E-10 |
| Stage1-vs-Stage2 |
2.253200E-01 |
| Stage1-vs-Stage3 |
9.404600E-01 |
| Stage1-vs-Stage4 |
1.645780E-02 |
| Stage2-vs-Stage3 |
2.927400E-01 |
| Stage2-vs-Stage4 |
1.493010E-01 |
| Stage3-vs-Stage4 |
3.555900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.92288415693065E-12 |
| Normal-vs-AfricanAmerican |
1.6423299999957E-05 |
| Normal-vs-Asian |
4.773100E-04 |
| Caucasian-vs-AfricanAmerican |
4.365000E-01 |
| Caucasian-vs-Asian |
7.660400E-01 |
| AfricanAmerican-vs-Asian |
3.637600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62503344114384E-12 |
| Normal-vs-Female |
1.045200E-04 |
| Male-vs-Female |
2.006100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.157800E-02 |
| Normal-vs-Extreme_Weight |
2.79509748679629E-11 |
| Normal-vs-Obese |
4.11370000286126E-08 |
| Normal-vs-Extreme_Obese |
2.10670000000412E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.251800E-02 |
| Normal_Weight-vs-Obese |
2.938200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.844420E-01 |
| Extreme_Weight-vs-Obese |
2.010100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.813350E-01 |
| Obese-vs-Extreme_Obese |
5.695800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.40960000338808E-08 |
| Normal-vs-Age(41-60Yrs) |
4.91639999822269E-08 |
| Normal-vs-Age(61-80Yrs) |
6.10811401458022E-12 |
| Normal-vs-Age(81-100Yrs) |
3.200200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.633200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.120000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.612800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.368970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.586400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.097400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.67139676835404E-11 |
| Normal-VS-Type2 PRCC |
2.177800E-03 |
| Normal-VS-KIRP CIMP |
2.036500E-04 |
| Normal-VS-Unclassified PRCC |
1.00499997213177E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.033950E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.868240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.490400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.243800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.627800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.381400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.74640002038285E-09 |
| Normal-vs-N1 |
8.07459654694753E-11 |
| Normal-vs-N2 |
6.608600E-04 |
| N0-vs-N1 |
1.755230E-01 |
| N0-vs-N2 |
3.361200E-01 |
| N1-vs-N2 |
3.516200E-01 |
|
|
